董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Robert Ford Chairman of the Board,Chief Executive Officer and Director 52 2419.87万美元 273.61 2026-04-24
Daniel J. Starks Director 71 36.09万美元 674.70 2026-04-24
John G. Stratton Director 65 38.86万美元 3.21 2026-04-24
Sally E. Blount Director 64 37.43万美元 3.41 2026-04-24
Darren W. McDew Director 65 33.59万美元 1.04 2026-04-24
Michelle A. Kumbier Director 58 34.19万美元 1.57 2026-04-24
Paola Gonzalez -- Director 54 34.19万美元 1.21 2026-04-24
Claire Babineaux Fontenot Director 61 36.69万美元 0.53 2026-04-24
Nita Ahuja Director 59 未披露 未持股 2026-04-24
Michael G. O Grady Director 60 33.59万美元 1.81 2026-04-24
Nancy McKinstry Director 67 40.67万美元 12.19 2026-04-24
Michael F. Roman Director 66 35.76万美元 1.44 2026-04-24

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Robert Ford Chairman of the Board,Chief Executive Officer and Director 52 2419.87万美元 273.61 2026-04-24
Daniel Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 47 653.43万美元 107.48 2026-04-24
Mary K. Moreland -- Executive Vice President, Human Resources 59 未披露 未持股 2026-04-24
Christopher J. Scoggins -- Executive Vice President, Diabetes Care 56 660.17万美元 41.39 2026-04-24
Philip P. Boudreau -- Executive Vice President, Finance and Chief Financial Officer 53 909.06万美元 24.21 2026-04-24
Louis H. Morrone -- Executive Vice President, Core Diagnostics 49 未披露 未持股 2026-04-24
John A. McCoy, Jr. Vice President, Finance and Controller 56 未披露 未持股 2026-04-24
Elizabeth C. Cushman -- Executive Vice President,General Counsel and Secretary 56 未披露 未持股 2026-04-24
Eric Shroff -- Senior Vice President, Rapid and Molecular Diagnostics 54 未披露 未持股 2026-04-24
Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 56 806.97万美元 46.74 2026-04-24

董事简历

中英对照 |  中文 |  英文
Robert Ford

Robert Ford,担任执行副总裁,负责医疗设备(2015年至今)、高级副总裁,负责糖尿病护理(2014年至2015年)、糖尿病护理贸易化运营副总裁(2008年至2014年)、公司职员(2008年)。


Robert Ford,2021 to present — Chairman of the Board and Chief Executive Officer, and Director.2020 to 2021 — President and Chief Executive Officer, and Director.2018 to 2020 — President and Chief Operating Officer, and Director since 2019.2015 to 2018 — Executive Vice President, Medical Devices.Elected Corporate Officer — 2008.
Robert Ford,担任执行副总裁,负责医疗设备(2015年至今)、高级副总裁,负责糖尿病护理(2014年至2015年)、糖尿病护理贸易化运营副总裁(2008年至2014年)、公司职员(2008年)。
Robert Ford,2021 to present — Chairman of the Board and Chief Executive Officer, and Director.2020 to 2021 — President and Chief Executive Officer, and Director.2018 to 2020 — President and Chief Operating Officer, and Director since 2019.2015 to 2018 — Executive Vice President, Medical Devices.Elected Corporate Officer — 2008.
Daniel J. Starks

Daniel J. Starks,曾担任St. Jude Medical, Inc.的董事长、总裁和首席执行官(2004年至2016年1月退休),随后担任董事会执行主席,直到2017年1月Abbott完成了对St. Jude Medical, Inc.的收购。他也曾担任St. Jude Medical, Inc.的总裁兼首席运营官(2001年至2004年),以及其总裁兼首席执行官,负责心脏节律管理业务(1997年至2001年)。


Daniel J. Starks Executive Chairman of the Board of St. Jude Medical, Inc., a medical device manufacturer, from January 2016 to January 2017, when Abbott completed its acquisition of St. Jude Medical. Chairman, President and Chief Executive Officer of St. Jude Medical from 2004 until his retirement in January 2016. President and Chief Operating Officer of St. Jude Medical from 2001 to 2004. President and CEO, Cardiac Rhythm Management Biness of St. Jude Medical from 1997 to 2001.
Daniel J. Starks,曾担任St. Jude Medical, Inc.的董事长、总裁和首席执行官(2004年至2016年1月退休),随后担任董事会执行主席,直到2017年1月Abbott完成了对St. Jude Medical, Inc.的收购。他也曾担任St. Jude Medical, Inc.的总裁兼首席运营官(2001年至2004年),以及其总裁兼首席执行官,负责心脏节律管理业务(1997年至2001年)。
Daniel J. Starks Executive Chairman of the Board of St. Jude Medical, Inc., a medical device manufacturer, from January 2016 to January 2017, when Abbott completed its acquisition of St. Jude Medical. Chairman, President and Chief Executive Officer of St. Jude Medical from 2004 until his retirement in January 2016. President and Chief Operating Officer of St. Jude Medical from 2001 to 2004. President and CEO, Cardiac Rhythm Management Biness of St. Jude Medical from 1997 to 2001.
John G. Stratton

John G. Stratton于2015年2月至2018年12月担任Verizon Communications Inc.执行副总裁兼全球运营总裁。此前,他曾于2014年4月至2015年2月担任执行副总裁兼全球企业和消费者有线业务总裁,2012年1月至2014年4月担任Verizon企业解决方案总裁,2010年10月至2012年1月担任Verizon Wireless首席运营官兼执行副总裁。斯特拉顿先生目前在通用动力公司董事会任职。2012年10月至2018年7月,斯特拉顿先生还担任总统国家安全电信咨询委员会成员,2015年2月至2018年7月,他还担任蜂窝通信行业协会理事。


John G. Stratton Executive Chairman of Frontier Communications Parent, Inc., a telecommunications company, from April 2021 to January 2026. Executive Vice President and President of Global Operations of Verizon Communications Inc. from 2015 to 2018. Executive Vice President and President of Global Enterprise and Consumer Wireline of Verizon from 2014 to 2015. President of Verizon Enterprise Solutions from 2012 to 2014. Chief Operating Officer and Executive Vice President of Verizon Wireless from 2010 to 2012. Member of The President's National Security Telecommunications Advisory Committee from 2012 to 2018. Director of the Cellular Telecommunications Indtry Association from 2015 to 2018.
John G. Stratton于2015年2月至2018年12月担任Verizon Communications Inc.执行副总裁兼全球运营总裁。此前,他曾于2014年4月至2015年2月担任执行副总裁兼全球企业和消费者有线业务总裁,2012年1月至2014年4月担任Verizon企业解决方案总裁,2010年10月至2012年1月担任Verizon Wireless首席运营官兼执行副总裁。斯特拉顿先生目前在通用动力公司董事会任职。2012年10月至2018年7月,斯特拉顿先生还担任总统国家安全电信咨询委员会成员,2015年2月至2018年7月,他还担任蜂窝通信行业协会理事。
John G. Stratton Executive Chairman of Frontier Communications Parent, Inc., a telecommunications company, from April 2021 to January 2026. Executive Vice President and President of Global Operations of Verizon Communications Inc. from 2015 to 2018. Executive Vice President and President of Global Enterprise and Consumer Wireline of Verizon from 2014 to 2015. President of Verizon Enterprise Solutions from 2012 to 2014. Chief Operating Officer and Executive Vice President of Verizon Wireless from 2010 to 2012. Member of The President's National Security Telecommunications Advisory Committee from 2012 to 2018. Director of the Cellular Telecommunications Indtry Association from 2015 to 2018.
Sally E. Blount

Sally E. Blount,她是芝加哥教区天主教慈善机构的首席执行官,也是西北大学凯洛格管理学院(Kellogg School of Management at Northwestern University) 2010-2018年的前任院长。她目前任职于Abbott Laboratories、the Joyce Foundation和the Economic Club of Chicago的董事会。她也是阿斯彭研究所商业和社会项目和芝加哥金融委员会的顾问委员会成员。她拥有15年的西北大学(Northwestern university)和纽约大学(New York university)商学院院长和高级大学管理人员的经验,以及30多年的西北大学凯洛格商学院(Kellogg school)本科、MBA、博士和高管级别的商业教育家经验。纽约大学斯特恩商学院(Stern School of Business)和芝加哥大学布斯商学院(University of Chicago Booth School of Business)。在职业生涯早期,她曾担任Eva Maddox Associates(现为Perkins + Will的一部分)的财务和规划总监,以及波士顿咨询集团(Boston Consulting Group)的副顾问。


Sally E. Blount Chief Executive Officer, Catholic Charities of the Archdiocese of Chicago, andMichael L. Nemmers Professor of Strategy and Former Dean of the J.L. KelloggGraduate School of Management at Northstern UniversityProfessional background;Chief Executive Officer of Catholic Charities of the Archdiocese of Chicago since 2020.Michael L. Nemmers Professor of Strategy at the J.L. Kellogg Graduate School of Management at Northstern University since 2010.Dean of the J.L. Kellogg Graduate School of Management at Northstern University from 2010 to 2018.Dean of the New York University Undergraduate College and Vice Dean of its Leonard N. Stern School of Biness from 2004 to 2010.Professor at the New York University Leonard School of Biness from 2001 to 2010, and became the Abraham L. Gitlow Professor of Management in 2004.Held academic posts at the University of Chicago's Graduate School of Biness from 1992 to 2001.Served on the Board of Directors of Ulta Beauty, Inc. from 2017 to 2022, the Board of Directors of the Economic Club of Chicago from 2017 to 2023, and the Board of Directors of the Joyce Foundation from 2017 through 2025.Key qualifications and expertiseAs a professor of management and strategy, having served as Dean of the J.L. Kellogg Graduate School of Management at Northstern University and as Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Biness, Dr. Blount provides Abbott's Board with expertise on biness organization, strategy, governance and management matters.
Sally E. Blount,她是芝加哥教区天主教慈善机构的首席执行官,也是西北大学凯洛格管理学院(Kellogg School of Management at Northwestern University) 2010-2018年的前任院长。她目前任职于Abbott Laboratories、the Joyce Foundation和the Economic Club of Chicago的董事会。她也是阿斯彭研究所商业和社会项目和芝加哥金融委员会的顾问委员会成员。她拥有15年的西北大学(Northwestern university)和纽约大学(New York university)商学院院长和高级大学管理人员的经验,以及30多年的西北大学凯洛格商学院(Kellogg school)本科、MBA、博士和高管级别的商业教育家经验。纽约大学斯特恩商学院(Stern School of Business)和芝加哥大学布斯商学院(University of Chicago Booth School of Business)。在职业生涯早期,她曾担任Eva Maddox Associates(现为Perkins + Will的一部分)的财务和规划总监,以及波士顿咨询集团(Boston Consulting Group)的副顾问。
Sally E. Blount Chief Executive Officer, Catholic Charities of the Archdiocese of Chicago, andMichael L. Nemmers Professor of Strategy and Former Dean of the J.L. KelloggGraduate School of Management at Northstern UniversityProfessional background;Chief Executive Officer of Catholic Charities of the Archdiocese of Chicago since 2020.Michael L. Nemmers Professor of Strategy at the J.L. Kellogg Graduate School of Management at Northstern University since 2010.Dean of the J.L. Kellogg Graduate School of Management at Northstern University from 2010 to 2018.Dean of the New York University Undergraduate College and Vice Dean of its Leonard N. Stern School of Biness from 2004 to 2010.Professor at the New York University Leonard School of Biness from 2001 to 2010, and became the Abraham L. Gitlow Professor of Management in 2004.Held academic posts at the University of Chicago's Graduate School of Biness from 1992 to 2001.Served on the Board of Directors of Ulta Beauty, Inc. from 2017 to 2022, the Board of Directors of the Economic Club of Chicago from 2017 to 2023, and the Board of Directors of the Joyce Foundation from 2017 through 2025.Key qualifications and expertiseAs a professor of management and strategy, having served as Dean of the J.L. Kellogg Graduate School of Management at Northstern University and as Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Biness, Dr. Blount provides Abbott's Board with expertise on biness organization, strategy, governance and management matters.
Darren W. McDew

Darren W. McDew是一名退休的四星上将,在美军服役36年,2018年10月退休。2015年8月至2018年8月,McDew将军担任美国运输司令部司令,是美国国防部全球空运、陆运和海运的唯一管理者。此前,他还担任参谋长联席会议战略计划和政策副主任、总统军事助理、空军公共事务主任和空军参议院联络处处长。McDew将军目前在帕森斯公司、劳斯莱斯、北美公司、联合服务汽车协会和美国男孩女孩俱乐部的董事会任职。


Darren W. McDew F star general who served for 36 years in the United States military before retiring in October 2018. Commander, U.S. Transportation Command, the single manager for global air, land and sea transportation for the U.S. Department of Defense from 2015 to 2018. Held vario leadership roles across the U.S. Military, including Vice Director for Strategic Plans and Policy for the Joint Chiefs of Staff, Military Aide to the President, Director of Air Force Public Affairs, and Chief of Air Force Senate Liaison Division. Serves on the Board of Directors of United Services Automobile Association, Boys & Girls Club of America, and Manns Home Youth Foundation.
Darren W. McDew是一名退休的四星上将,在美军服役36年,2018年10月退休。2015年8月至2018年8月,McDew将军担任美国运输司令部司令,是美国国防部全球空运、陆运和海运的唯一管理者。此前,他还担任参谋长联席会议战略计划和政策副主任、总统军事助理、空军公共事务主任和空军参议院联络处处长。McDew将军目前在帕森斯公司、劳斯莱斯、北美公司、联合服务汽车协会和美国男孩女孩俱乐部的董事会任职。
Darren W. McDew F star general who served for 36 years in the United States military before retiring in October 2018. Commander, U.S. Transportation Command, the single manager for global air, land and sea transportation for the U.S. Department of Defense from 2015 to 2018. Held vario leadership roles across the U.S. Military, including Vice Director for Strategic Plans and Policy for the Joint Chiefs of Staff, Military Aide to the President, Director of Air Force Public Affairs, and Chief of Air Force Senate Liaison Division. Serves on the Board of Directors of United Services Automobile Association, Boys & Girls Club of America, and Manns Home Youth Foundation.
Michelle A. Kumbier

Michelle A. Kumbier于2017年10月至2020年4月担任哈雷戴维森汽车公司前首席运营官。Kumbier女士曾于2015年5月至2017年10月担任哈雷戴维森汽车公司产品和运营高级副总裁,2012年9月至2015年4月担任哈雷戴维森摩托车运营高级副总裁,2010年11月至2012年8月担任哈雷戴维森产品开发高级副总裁。她的职业生涯始于1997年任职Harley-Davidson公司。加入Harley-Davidson之前,Kumbier女士于1986年在科勒公司工作,在那里她在管道产品和发动机部门担任过各种职位。Kumbier女士自2018年起担任雅培实验室董事会成员。Kumbier女士是Teledyne Technologies Incorporated审计委员会和人事与薪酬委员会的成员。


Michelle A. Kumbier has been Senior Vice President and President, Turf & Consumer Products, of Briggs & Stratton, LLC, a privately held manufacturer and marketer of engines, batteries and outdoor por equipment, since March 2022. She is the former Senior Vice President and Chief Operating Officer of Harley Davidson Motor Company, a manufacturer of motorcycles and related products, from October 2017 to April 2020. Ms. Kumbier had previoly served as Harley Davidson's Senior Vice President, Motor Company Product and Operations from May 2015 to October 2017, and held vario other executive roles from 1997 to 2015. Prior to joining Harley Davidson in 1997, Ms. Kumbier began her career at Kohler Company in 1986, where she held a variety of positions in both the plumbing products and engines divisions. Ms. Kumbier has also been a member of the Board of Directors of Abbott Laboratories, a health care products provider, since 2018, and Ryerson Holding Corporation, a value added processor and distributor of indtrial metals, since April 2024. She is a member of the audit committee of Ryerson Holding Corporation and the audit committee and compensation committee of Abbott Laboratories. She was a member of the Board of Directors of Tenneco Inc. from Augt 2021 to November 2022.
Michelle A. Kumbier于2017年10月至2020年4月担任哈雷戴维森汽车公司前首席运营官。Kumbier女士曾于2015年5月至2017年10月担任哈雷戴维森汽车公司产品和运营高级副总裁,2012年9月至2015年4月担任哈雷戴维森摩托车运营高级副总裁,2010年11月至2012年8月担任哈雷戴维森产品开发高级副总裁。她的职业生涯始于1997年任职Harley-Davidson公司。加入Harley-Davidson之前,Kumbier女士于1986年在科勒公司工作,在那里她在管道产品和发动机部门担任过各种职位。Kumbier女士自2018年起担任雅培实验室董事会成员。Kumbier女士是Teledyne Technologies Incorporated审计委员会和人事与薪酬委员会的成员。
Michelle A. Kumbier has been Senior Vice President and President, Turf & Consumer Products, of Briggs & Stratton, LLC, a privately held manufacturer and marketer of engines, batteries and outdoor por equipment, since March 2022. She is the former Senior Vice President and Chief Operating Officer of Harley Davidson Motor Company, a manufacturer of motorcycles and related products, from October 2017 to April 2020. Ms. Kumbier had previoly served as Harley Davidson's Senior Vice President, Motor Company Product and Operations from May 2015 to October 2017, and held vario other executive roles from 1997 to 2015. Prior to joining Harley Davidson in 1997, Ms. Kumbier began her career at Kohler Company in 1986, where she held a variety of positions in both the plumbing products and engines divisions. Ms. Kumbier has also been a member of the Board of Directors of Abbott Laboratories, a health care products provider, since 2018, and Ryerson Holding Corporation, a value added processor and distributor of indtrial metals, since April 2024. She is a member of the audit committee of Ryerson Holding Corporation and the audit committee and compensation committee of Abbott Laboratories. She was a member of the Board of Directors of Tenneco Inc. from Augt 2021 to November 2022.
Paola Gonzalez

Paola Gonzalez 自 2018 年 1 月起担任消费品和专业产品制造商和营销商 Clorox 公司副总裁兼财务主管。2010 年至 2017 年担任 Clorox 财务、家庭和生活方式部门副总裁。财务副总裁,全球战略计划 从 2008 年到 2010 年,Clorox。自 1997 年加入 Clorox 以来,在整个 Clorox 担任过各种财务领导职务。在 Clorox 之前,曾在拉丁美洲的美国航空公司从事财务工作。


Paola Gonzalez,Vice President and Treasurer of The Clorox Company, a manufacturer and marketer of consumer and professional products, since January 2018.Vice President of Finance, Household and Lifestyle Segments of Clorox from 2010 to 2017.Vice President of Finance, Global Strategic Initiatives of Clorox from 2008 to 2010.Held various leadership roles in finance across Clorox since joining Clorox in 1997.Prior to Clorox, worked in finance for American Airlines in Latin America.
Paola Gonzalez 自 2018 年 1 月起担任消费品和专业产品制造商和营销商 Clorox 公司副总裁兼财务主管。2010 年至 2017 年担任 Clorox 财务、家庭和生活方式部门副总裁。财务副总裁,全球战略计划 从 2008 年到 2010 年,Clorox。自 1997 年加入 Clorox 以来,在整个 Clorox 担任过各种财务领导职务。在 Clorox 之前,曾在拉丁美洲的美国航空公司从事财务工作。
Paola Gonzalez,Vice President and Treasurer of The Clorox Company, a manufacturer and marketer of consumer and professional products, since January 2018.Vice President of Finance, Household and Lifestyle Segments of Clorox from 2010 to 2017.Vice President of Finance, Global Strategic Initiatives of Clorox from 2008 to 2010.Held various leadership roles in finance across Clorox since joining Clorox in 1997.Prior to Clorox, worked in finance for American Airlines in Latin America.
Claire Babineaux Fontenot

Claire Babineaux Fontenot,自2018年起担任美国饥饿救济慈善组织Feeding America的首席执行官。自2017年以来,她是CBF Consulting Group, LLC(一家商业咨询公司)的创始人。2014年至2017年,担任Walmart Inc.(一家经营超级中心、折扣百货商店和电子商务网站的跨国零售公司)的执行副总裁兼全球财务主管。2007年至2014年,担任Walmart高级副总裁兼首席税务官。2004年至2007年,担任Walmart审计和税收政策副总裁。从2018年到2019年,她担任Charah Solutions, Inc.的董事会成员。


Claire Babineaux Fontenot Chief Executive Officer, Feeding AmericaProfessional background;Chief Executive Officer of Feeding America, a U.S. hunger relief charitable organization, since October 2018. Ms. Babineaux Fontenot has announced her retirement after a period of transition in 2026. Founder of CBF Consulting Group, LLC, a biness consulting firm, since 2017.Executive Vice President and Global Treasurer of Walmart Inc., a multinational retail corporation operating supercenters, discount department stores, and eCommerce bsites, from 2014 to 2017.Senior Vice President and Chief Tax Officer of Walmart, from 2007 to 2014.Vice President of Audits and Tax Policy of Walmart, from 2004 to 2007.Serves on the Board of Directors of New York Life Insurance Company.Key qualifications and expertiseAs the Chief Executive Officer of Feeding America, Ms. Babineaux Fontenot provides Abbott's Board with substantial experience in organizational governance, strategic planning, and supply chain and infrastructure management, and through her prior financial leadership roles at Walmart, Ms. Babineaux Fontenot contributes extensive expertise and knowledge of global risk management and corporate finance and accounting matters for a multinational public company.
Claire Babineaux Fontenot,自2018年起担任美国饥饿救济慈善组织Feeding America的首席执行官。自2017年以来,她是CBF Consulting Group, LLC(一家商业咨询公司)的创始人。2014年至2017年,担任Walmart Inc.(一家经营超级中心、折扣百货商店和电子商务网站的跨国零售公司)的执行副总裁兼全球财务主管。2007年至2014年,担任Walmart高级副总裁兼首席税务官。2004年至2007年,担任Walmart审计和税收政策副总裁。从2018年到2019年,她担任Charah Solutions, Inc.的董事会成员。
Claire Babineaux Fontenot Chief Executive Officer, Feeding AmericaProfessional background;Chief Executive Officer of Feeding America, a U.S. hunger relief charitable organization, since October 2018. Ms. Babineaux Fontenot has announced her retirement after a period of transition in 2026. Founder of CBF Consulting Group, LLC, a biness consulting firm, since 2017.Executive Vice President and Global Treasurer of Walmart Inc., a multinational retail corporation operating supercenters, discount department stores, and eCommerce bsites, from 2014 to 2017.Senior Vice President and Chief Tax Officer of Walmart, from 2007 to 2014.Vice President of Audits and Tax Policy of Walmart, from 2004 to 2007.Serves on the Board of Directors of New York Life Insurance Company.Key qualifications and expertiseAs the Chief Executive Officer of Feeding America, Ms. Babineaux Fontenot provides Abbott's Board with substantial experience in organizational governance, strategic planning, and supply chain and infrastructure management, and through her prior financial leadership roles at Walmart, Ms. Babineaux Fontenot contributes extensive expertise and knowledge of global risk management and corporate finance and accounting matters for a multinational public company.
Nita Ahuja

Nita Ahuja威斯康辛大学医学与公共卫生学院院长、医疗事务副校长、外科系教授专业背景;威斯康辛大学医学与公共卫生学院院长、医疗事务副校长、外科系教授,自2025年5月起担任威斯康辛大学医院和诊所管理局董事会候补主席或副主席。2018年至2025年担任耶鲁大学医学院外科系主任,耶鲁纽黑文卫生系统首席外科医生、耶鲁纽黑文医院董事会成员,2020年至2025年担任耶鲁大学医学院实践计划主席,2021年至2022年担任耶鲁大学癌症中心临时主任。2014年至2018年担任约翰霍普金斯大学医学院外科系学术事务副主席,首席,2016年至2018年在约翰霍普金斯医院担任外科肿瘤科。担任美国国家医学科学院当选成员和美国医学院协会董事会成员,并曾担任美国外科医学院癌症委员会的当选国家代表。关键资历和专长通过她在领先医疗机构的丰富领导经验和作为执业外科医生的专业知识,Ahuja博士为董事会提供了对医学科学和医疗保健交付的深刻理解,包括对研发计划和战略重点、医疗技术以及不断发展的医疗保健环境的宝贵视角。


Nita Ahuja Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, and Professor in the Department of SurgeryProfessional background;Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, Professor in the Department of Surgery, and alternating Chair or Vice Chair of the Board of the University of Wisconsin Hospitals and Clinics Authority since May 2025.Chair of the Department of Surgery at Yale School of Medicine from 2018 to 2025, Surgeon in Chief for Yale New Haven Health System and Board member of Yale New Haven Hospital from 2020 to 2025, Chair of the Yale Medicine Faculty Practice Plan from 2020 to 2024, and Interim Chief of the Yale Cancer Center from 2021 to 2022.Vice Chair of Academic Affairs, Department of Surgery at the Johns Hopkins University School of Medicine from 2014 to 2018, and Chief, Division of Surgical Oncology at The Johns Hopkins Hospital from 2016 to 2018.Serves as an elected member of the National Academy of Medicine and on the Board of Directors of the Association of American Medical Colleges, and has served as an elected national representative to the Commission on Cancer for the American College of Surgeons. Key qualifications and expertiseThrough her extensive leadership experience at leading medical institutions and her expertise as a practicing surgeon, Dr. Ahuja provides the Board with deep understanding of medical science and healthcare delivery, including valuable perspectives on research and development initiatives and strategic priorities, medical technologies, and the evolving healthcare environment.
Nita Ahuja威斯康辛大学医学与公共卫生学院院长、医疗事务副校长、外科系教授专业背景;威斯康辛大学医学与公共卫生学院院长、医疗事务副校长、外科系教授,自2025年5月起担任威斯康辛大学医院和诊所管理局董事会候补主席或副主席。2018年至2025年担任耶鲁大学医学院外科系主任,耶鲁纽黑文卫生系统首席外科医生、耶鲁纽黑文医院董事会成员,2020年至2025年担任耶鲁大学医学院实践计划主席,2021年至2022年担任耶鲁大学癌症中心临时主任。2014年至2018年担任约翰霍普金斯大学医学院外科系学术事务副主席,首席,2016年至2018年在约翰霍普金斯医院担任外科肿瘤科。担任美国国家医学科学院当选成员和美国医学院协会董事会成员,并曾担任美国外科医学院癌症委员会的当选国家代表。关键资历和专长通过她在领先医疗机构的丰富领导经验和作为执业外科医生的专业知识,Ahuja博士为董事会提供了对医学科学和医疗保健交付的深刻理解,包括对研发计划和战略重点、医疗技术以及不断发展的医疗保健环境的宝贵视角。
Nita Ahuja Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, and Professor in the Department of SurgeryProfessional background;Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, Professor in the Department of Surgery, and alternating Chair or Vice Chair of the Board of the University of Wisconsin Hospitals and Clinics Authority since May 2025.Chair of the Department of Surgery at Yale School of Medicine from 2018 to 2025, Surgeon in Chief for Yale New Haven Health System and Board member of Yale New Haven Hospital from 2020 to 2025, Chair of the Yale Medicine Faculty Practice Plan from 2020 to 2024, and Interim Chief of the Yale Cancer Center from 2021 to 2022.Vice Chair of Academic Affairs, Department of Surgery at the Johns Hopkins University School of Medicine from 2014 to 2018, and Chief, Division of Surgical Oncology at The Johns Hopkins Hospital from 2016 to 2018.Serves as an elected member of the National Academy of Medicine and on the Board of Directors of the Association of American Medical Colleges, and has served as an elected national representative to the Commission on Cancer for the American College of Surgeons. Key qualifications and expertiseThrough her extensive leadership experience at leading medical institutions and her expertise as a practicing surgeon, Dr. Ahuja provides the Board with deep understanding of medical science and healthcare delivery, including valuable perspectives on research and development initiatives and strategic priorities, medical technologies, and the evolving healthcare environment.
Michael G. O Grady

Michael G. O Grady,2011年加入北方信托,2019年起担任董事会主席,2018年起担任首席执行官,2017年起担任总裁。在此之前,O'Grady先生于2014年至2016年担任执行副总裁兼企业与机构服务总裁,并于2011年至2014年担任首席财务官。在加入北方信托之前,O'Grady先生曾在美银美林投资银行集团担任董事总经理。


Michael G. O Grady joined Northern Trt in 2011 and has served as Chairman of the Board since 2019, as Chief Executive Officer since 2018 and as President since 2017. Prior to that, Mr. O'Grady served as Executive Vice President and President of Corporate & Institutional Services from 2014 to 2016 and as Chief Financial Officer from 2011 to 2014. Before joining Northern Trt, Mr. O'Grady served as a Managing Director in Bank of America Merrill Lynch's Investment Banking Group.
Michael G. O Grady,2011年加入北方信托,2019年起担任董事会主席,2018年起担任首席执行官,2017年起担任总裁。在此之前,O'Grady先生于2014年至2016年担任执行副总裁兼企业与机构服务总裁,并于2011年至2014年担任首席财务官。在加入北方信托之前,O'Grady先生曾在美银美林投资银行集团担任董事总经理。
Michael G. O Grady joined Northern Trt in 2011 and has served as Chairman of the Board since 2019, as Chief Executive Officer since 2018 and as President since 2017. Prior to that, Mr. O'Grady served as Executive Vice President and President of Corporate & Institutional Services from 2014 to 2016 and as Chief Financial Officer from 2011 to 2014. Before joining Northern Trt, Mr. O'Grady served as a Managing Director in Bank of America Merrill Lynch's Investment Banking Group.
Nancy McKinstry

Nancy McKinstry,自2003年9月,她一直担任威科NV的首席执行官兼执行董事会主席。2001年6月,她担任执行董事会成员。她担任SANOMA公司的董事。她还担任罗德岛大学的顾问委员会、阿姆斯特丹金融学院咨询委员会、哥伦比亚大学商学院董事会、哈林顿传播和媒体学院顾问委员会的成员。2004年至2012年,她担任Telefonieaktiebolaget爱立信LM爱立信电话公司的董事。从2004年到2007年,她还担任MortgageIT控股公司的董事。威科集团NV、尔芬AAN巢穴Rijn、荷兰(全球信息,软件和服务提供商)的执行董事会主席 。


Nancy McKinstry,has been chief executive officer and chairman of the executive board (a board made up of solely management members, which is distinct from Wolters Kluwer's independent supervisory board) of Wolters Kluwer N.V. ("Wolters Kluwer"), a global professional information services and solutions company, since September 2003 and a member of its executive board since 2001. Before assuming her current position, Ms. McKinstry gained more than a decade of experience with Wolters Kluwer and its North American subsidiaries, serving as chief executive officer of CCH Legal Information Services for three years and as chief executive officer of operations in North America. Earlier in her career, she was a principal with Booz & Company (formerly Booz Allen Hamilton Inc.), focusing on media and technology.Ms. McKinstry is a director of Abbott Laboratories.Ms. McKinstry earned a Bachelor of Arts degree in Economics from the University of Rhode Island, Kingston and holds an MBA in Finance and Marketing from Columbia University.
Nancy McKinstry,自2003年9月,她一直担任威科NV的首席执行官兼执行董事会主席。2001年6月,她担任执行董事会成员。她担任SANOMA公司的董事。她还担任罗德岛大学的顾问委员会、阿姆斯特丹金融学院咨询委员会、哥伦比亚大学商学院董事会、哈林顿传播和媒体学院顾问委员会的成员。2004年至2012年,她担任Telefonieaktiebolaget爱立信LM爱立信电话公司的董事。从2004年到2007年,她还担任MortgageIT控股公司的董事。威科集团NV、尔芬AAN巢穴Rijn、荷兰(全球信息,软件和服务提供商)的执行董事会主席 。
Nancy McKinstry,has been chief executive officer and chairman of the executive board (a board made up of solely management members, which is distinct from Wolters Kluwer's independent supervisory board) of Wolters Kluwer N.V. ("Wolters Kluwer"), a global professional information services and solutions company, since September 2003 and a member of its executive board since 2001. Before assuming her current position, Ms. McKinstry gained more than a decade of experience with Wolters Kluwer and its North American subsidiaries, serving as chief executive officer of CCH Legal Information Services for three years and as chief executive officer of operations in North America. Earlier in her career, she was a principal with Booz & Company (formerly Booz Allen Hamilton Inc.), focusing on media and technology.Ms. McKinstry is a director of Abbott Laboratories.Ms. McKinstry earned a Bachelor of Arts degree in Economics from the University of Rhode Island, Kingston and holds an MBA in Finance and Marketing from Columbia University.
Michael F. Roman

Michael F. Roman自2017年7月起担任3M公司的首席运营官兼执行副总裁,直接负责3M的五个业务集团和公司的国际业务。 Roman先生于2014年6月至2017年7月担任3M公司工业业务集团执行副总裁。Roman先生于2013年5月至2014年6月担任公司业务发展高级副总裁。在此之前,他 2011年9月至2013年5月,他担任工业胶粘剂和胶带部门的副总裁兼总经理。罗曼先生还曾在全球范围内生活并领导3M业务,包括美国,欧洲和亚洲。 罗曼明尼苏达大学和南加州大学电子工程学士和硕士学位。


Michael F. Roman Executive Chairman of the Board of 3M Company, a global manufacturing and technology company, from May 2024 to March 2025. Chairman of the Board, President and Chief Executive Officer of 3M from 2019 to 2024. Chief Executive Officer of 3M from 2018 to 2019. Chief Operating Officer and Executive Vice President of 3M from 2017 to 2018 with direct responsibilities for 3M's five biness groups and its international operations. Executive Vice President, Indtrial Biness Group of 3M from 2014 to 2017. Senior Vice President, Biness Development of 3M from 2013 to 2014. Vice President and General Manager of Indtrial Adhesives and Tapes Division of 3M from 2011 to 2013.
Michael F. Roman自2017年7月起担任3M公司的首席运营官兼执行副总裁,直接负责3M的五个业务集团和公司的国际业务。 Roman先生于2014年6月至2017年7月担任3M公司工业业务集团执行副总裁。Roman先生于2013年5月至2014年6月担任公司业务发展高级副总裁。在此之前,他 2011年9月至2013年5月,他担任工业胶粘剂和胶带部门的副总裁兼总经理。罗曼先生还曾在全球范围内生活并领导3M业务,包括美国,欧洲和亚洲。 罗曼明尼苏达大学和南加州大学电子工程学士和硕士学位。
Michael F. Roman Executive Chairman of the Board of 3M Company, a global manufacturing and technology company, from May 2024 to March 2025. Chairman of the Board, President and Chief Executive Officer of 3M from 2019 to 2024. Chief Executive Officer of 3M from 2018 to 2019. Chief Operating Officer and Executive Vice President of 3M from 2017 to 2018 with direct responsibilities for 3M's five biness groups and its international operations. Executive Vice President, Indtrial Biness Group of 3M from 2014 to 2017. Senior Vice President, Biness Development of 3M from 2013 to 2014. Vice President and General Manager of Indtrial Adhesives and Tapes Division of 3M from 2011 to 2013.

高管简历

中英对照 |  中文 |  英文
Robert Ford

Robert Ford,担任执行副总裁,负责医疗设备(2015年至今)、高级副总裁,负责糖尿病护理(2014年至2015年)、糖尿病护理贸易化运营副总裁(2008年至2014年)、公司职员(2008年)。


Robert Ford,2021 to present — Chairman of the Board and Chief Executive Officer, and Director.2020 to 2021 — President and Chief Executive Officer, and Director.2018 to 2020 — President and Chief Operating Officer, and Director since 2019.2015 to 2018 — Executive Vice President, Medical Devices.Elected Corporate Officer — 2008.
Robert Ford,担任执行副总裁,负责医疗设备(2015年至今)、高级副总裁,负责糖尿病护理(2014年至2015年)、糖尿病护理贸易化运营副总裁(2008年至2014年)、公司职员(2008年)。
Robert Ford,2021 to present — Chairman of the Board and Chief Executive Officer, and Director.2020 to 2021 — President and Chief Executive Officer, and Director.2018 to 2020 — President and Chief Operating Officer, and Director since 2019.2015 to 2018 — Executive Vice President, Medical Devices.Elected Corporate Officer — 2008.
Daniel Salvadori

Daniel Salvadori,2014年至今,他担任拉丁美洲建立药品高级副总裁。从2013年到2014年,他担任CFR Pharmaceuticals S.A.(拉丁美洲的制药公司)的拉丁美洲首席执行官。从2012年到2013年,他担任CFR Pharmaceuticals S.A.的复杂治疗部门执行总裁。从2010年到2012年,他担任 Sandoz Pharmaceuticals和Novartis AG (瑞士跨国制药公司)拉丁美洲销售和市场营销负责人。2014年他当选公司官员。


Daniel Salvadori,2021 to present — Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products.2017 to 2021 — Executive Vice President, Nutritional Products.Elected Corporate Officer — 2014.
Daniel Salvadori,2014年至今,他担任拉丁美洲建立药品高级副总裁。从2013年到2014年,他担任CFR Pharmaceuticals S.A.(拉丁美洲的制药公司)的拉丁美洲首席执行官。从2012年到2013年,他担任CFR Pharmaceuticals S.A.的复杂治疗部门执行总裁。从2010年到2012年,他担任 Sandoz Pharmaceuticals和Novartis AG (瑞士跨国制药公司)拉丁美洲销售和市场营销负责人。2014年他当选公司官员。
Daniel Salvadori,2021 to present — Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products.2017 to 2021 — Executive Vice President, Nutritional Products.Elected Corporate Officer — 2014.
Mary K. Moreland

Mary K. Moreland2019年至今-人力资源执行副总裁。2013年至2019年-薪酬,福利和人力资源并购部门副总裁。当选公司总监-2019年。


Mary K. Moreland,2019 to present — Executive Vice President, Human Resources.2013 to 2019 — Divisional Vice President, Compensation, Benefits and HR M&A.Elected Corporate Officer — 2019.
Mary K. Moreland2019年至今-人力资源执行副总裁。2013年至2019年-薪酬,福利和人力资源并购部门副总裁。当选公司总监-2019年。
Mary K. Moreland,2019 to present — Executive Vice President, Human Resources.2013 to 2019 — Divisional Vice President, Compensation, Benefits and HR M&A.Elected Corporate Officer — 2019.
Christopher J. Scoggins

Christopher J. Scoggins,2019年至今-Rapid Diagnostics高级副总裁。2015年至2019年-商业运营糖尿病护理副总裁。2011年至2015年-ADC欧洲,中东和非洲地区商业运营部门副总裁,当选公司官员-2015年。


Christopher J. Scoggins,2019 to present,Senior Vice President, Rapid Diagnostics.2015 to 2019Vice President, Diabetes Care, Commercial Operations.2015Elected Corporate Officer.
Christopher J. Scoggins,2019年至今-Rapid Diagnostics高级副总裁。2015年至2019年-商业运营糖尿病护理副总裁。2011年至2015年-ADC欧洲,中东和非洲地区商业运营部门副总裁,当选公司官员-2015年。
Christopher J. Scoggins,2019 to present,Senior Vice President, Rapid Diagnostics.2015 to 2019Vice President, Diabetes Care, Commercial Operations.2015Elected Corporate Officer.
Philip P. Boudreau

Philip P. Boudreau,2020年至今,财务副总裁兼财务总监。2017年至2020年,医疗器械部门副总裁兼财务总监。2012年至2017年,医疗点部门副总裁兼财务总监兼商业支持。2020年,当选雅培公司高管。


Philip P. Boudreau,2023 to present — Senior Vice President, Finance and Chief Financial Officer.2020 to 2023 — Vice President, Finance and Controller.2017 to 2020 — Divisional Vice President, Controller, Medical Devices.Elected Corporate Officer — 2020.
Philip P. Boudreau,2020年至今,财务副总裁兼财务总监。2017年至2020年,医疗器械部门副总裁兼财务总监。2012年至2017年,医疗点部门副总裁兼财务总监兼商业支持。2020年,当选雅培公司高管。
Philip P. Boudreau,2023 to present — Senior Vice President, Finance and Chief Financial Officer.2020 to 2023 — Vice President, Finance and Controller.2017 to 2020 — Divisional Vice President, Controller, Medical Devices.Elected Corporate Officer — 2020.
Louis H. Morrone

Louis H. Morrone,现任高级副总裁,快速诊断。2017至2021 -副总裁输血医学。2015年至2017年——输血医学部门副总裁兼总经理。当选公司高管——2017年。


Louis H. Morrone,2023 to present — Executive Vice President, Core Diagnostics.2021 to 2023 — Senior Vice President, Rapid Diagnostics.2017 to 2021 — Vice President, Transfusion Medicine.Elected Corporate Officer — 2017.
Louis H. Morrone,现任高级副总裁,快速诊断。2017至2021 -副总裁输血医学。2015年至2017年——输血医学部门副总裁兼总经理。当选公司高管——2017年。
Louis H. Morrone,2023 to present — Executive Vice President, Core Diagnostics.2021 to 2023 — Senior Vice President, Rapid Diagnostics.2017 to 2021 — Vice President, Transfusion Medicine.Elected Corporate Officer — 2017.
John A. McCoy, Jr.

John A. McCoy, Jr.,自2021年起担任雅培副总裁兼财务主管,并于2018年至2021年担任快速诊断部门副总裁兼财务总监,并于2017年至2018年担任财务共享服务部门副总裁。他于2017年加入雅培,并于2021年成为公司官员。加入雅培之前,他曾担任Baxalta Incorporated的高级副总裁兼公司财务总监(2015年至2017年)。


John A. McCoy, Jr.,2023 to present — Vice President, Finance and Controller.2021 to 2023 — Vice President, Treasurer.2018 to 2021 — Divisional Vice President, Controller, Rapid Diagnostics.Elected Corporate Officer — 2021.
John A. McCoy, Jr.,自2021年起担任雅培副总裁兼财务主管,并于2018年至2021年担任快速诊断部门副总裁兼财务总监,并于2017年至2018年担任财务共享服务部门副总裁。他于2017年加入雅培,并于2021年成为公司官员。加入雅培之前,他曾担任Baxalta Incorporated的高级副总裁兼公司财务总监(2015年至2017年)。
John A. McCoy, Jr.,2023 to present — Vice President, Finance and Controller.2021 to 2023 — Vice President, Treasurer.2018 to 2021 — Divisional Vice President, Controller, Rapid Diagnostics.Elected Corporate Officer — 2021.
Elizabeth C. Cushman

Elizabeth C. Cushman,2025年至今——执行副总裁、总法律顾问和秘书;2024年至2025年——高级副总裁,法律;2023年至2024年——副总裁,专业法律;2021年至2023年——部门副总裁兼协理总法律顾问,法律监管和合规;当选公司官员—— 2023年。


Elizabeth C. Cushman,2025 to present — Executive Vice President, General Counsel and Secretary;2024 to 2025 — Senior Vice President, Legal;2023 to 2024 — Vice President, Specialty Legal;2021 to 2023 — Divisional Vice President and Associate General Counsel, Legal Regulatory and Compliance;Elected Corporate Officer — 2023.
Elizabeth C. Cushman,2025年至今——执行副总裁、总法律顾问和秘书;2024年至2025年——高级副总裁,法律;2023年至2024年——副总裁,专业法律;2021年至2023年——部门副总裁兼协理总法律顾问,法律监管和合规;当选公司官员—— 2023年。
Elizabeth C. Cushman,2025 to present — Executive Vice President, General Counsel and Secretary;2024 to 2025 — Senior Vice President, Legal;2023 to 2024 — Vice President, Specialty Legal;2021 to 2023 — Divisional Vice President and Associate General Counsel, Legal Regulatory and Compliance;Elected Corporate Officer — 2023.
Eric Shroff

Eric Shroff,2025年至今——快速和分子诊断高级副总裁;2018年至2025年—— Abbott Point of Care副总裁;当选公司官员—— 2018年。


Eric Shroff,2025 to present — Senior Vice President, Rapid and Molecular Diagnostics;2018 to 2025 — Vice President, Abbott Point of Care;Elected Corporate Officer — 2018.
Eric Shroff,2025年至今——快速和分子诊断高级副总裁;2018年至2025年—— Abbott Point of Care副总裁;当选公司官员—— 2018年。
Eric Shroff,2025 to present — Senior Vice President, Rapid and Molecular Diagnostics;2018 to 2025 — Vice President, Abbott Point of Care;Elected Corporate Officer — 2018.
Lisa D. Earnhardt

Lisa D. Earnhardt从2008年3月开始担任Abbott Laboratories 总裁兼首席执行官,并担任董事,加入Abbott Laboratories 前,从2006年6月到2008年1月,Earnhardt女士担任波士顿科技公司(Boston Scientific)的心脏病外科手术部门的总裁直到其被出售给洁定集团(Getinge Group),前者以前叫美国佳滕公司(Guidant Corporation)或Guidant。从1996年8月到2006年4月,Earnhardt女士在Guidant任职,担任多个销售与市场部的领导职位。Earnhardt女士从2011年开始担任Kensey Nash的董事直到其于2012年被Royal DSM NA收购,前者是一家上市公司,她在该公司担任董事会的提名与治理和审计委员会委员。Earnhardt女士担任凯洛格商学院校友理事会(Kellogg Alumni Council)的主席。Earnhardt女士在西北大学凯洛格管理学院(Northwestern’s Kellogg School of Management )获得工商管理硕士学位,并在斯坦福大学(Stanford University)获得工业工程理学士学位。


Lisa D. Earnhardt,2023 to present — Executive Vice President and Group President, Medical Devices.2019 to 2023 — Executive Vice President, Medical Devices.2008 to 2019 — President, CEO, and Director, Intersect ENT (a medical technology company focused on developing treatments for ear, nose and throat conditions).Elected Corporate Officer — 2019.
Lisa D. Earnhardt从2008年3月开始担任Abbott Laboratories 总裁兼首席执行官,并担任董事,加入Abbott Laboratories 前,从2006年6月到2008年1月,Earnhardt女士担任波士顿科技公司(Boston Scientific)的心脏病外科手术部门的总裁直到其被出售给洁定集团(Getinge Group),前者以前叫美国佳滕公司(Guidant Corporation)或Guidant。从1996年8月到2006年4月,Earnhardt女士在Guidant任职,担任多个销售与市场部的领导职位。Earnhardt女士从2011年开始担任Kensey Nash的董事直到其于2012年被Royal DSM NA收购,前者是一家上市公司,她在该公司担任董事会的提名与治理和审计委员会委员。Earnhardt女士担任凯洛格商学院校友理事会(Kellogg Alumni Council)的主席。Earnhardt女士在西北大学凯洛格管理学院(Northwestern’s Kellogg School of Management )获得工商管理硕士学位,并在斯坦福大学(Stanford University)获得工业工程理学士学位。
Lisa D. Earnhardt,2023 to present — Executive Vice President and Group President, Medical Devices.2019 to 2023 — Executive Vice President, Medical Devices.2008 to 2019 — President, CEO, and Director, Intersect ENT (a medical technology company focused on developing treatments for ear, nose and throat conditions).Elected Corporate Officer — 2019.